Automated radiomics model for preoperative pancreatic neuroendocrine tumor grade prediction.

P Pratik Chandra (Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY) N Naaz Nasar (Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY) H Hadi Ghahremannezhad (Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY) K Kevin Soares V Vinod P. Balachandran J Jeffrey A. Drebin (Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY) M Michael Ian D'Angelica (Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY) T T. Peter Kingham W William R. Jarnagin J Jayasree Chakraborty (Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY) A Alice Chia-chi Wei (Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY)

Abstract

655 Background: Pancreatic neuroendocrine tumors (PNETs) have varying biologic behavior based on factors including tumor grade. Many prognostic factors can only be determined post-pancreatectomy; thus, are unable to guide clinical decision making preoperatively. This is particularly relevant in small, non-functional (NF)-PNETs. Imaging analysis with radiomics may be able to elucidate biologic data such as tumor grade, without the need for tissue sampling. Our study aims to create an automatic pipeline from segmentation to radiomics-signature building to preoperatively predict tumor grade. Methods: Patients that underwent resection between 2003-21 with adequate preoperative arterial phase CT scans were divided into training and validation cohorts. In the training cohort, the pancreas and tumor region were manually segmented and used to train an auto-segmentation model. The validation cohort then underwent automatic segmentation. A total of 255 radiomics features were extracted from the tumor region. Correlated features were removed, and the minimum redundancy maximum relevance (mRMR) method was used to select the final feature set. These features were used to train a Support Vector Machine (SVM)-based classifier through the training cohort to predict grade, which was dichotomized into grade I versus II/III. The radiomic based prediction model was then evaluated in the automatically segmented validation cohort. Results: A total of 186 patients were identified and divided into training (n = 140) and validation (n = 46) cohorts. Median age was 57 (27, 85) and 52% were male. 113 (62%) and 70 (38%) patients were grades I and II/III, respectively. Median tumor size was 24 mm (6, 200) and 43 (26%) patients had positive nodal disease. The auto-segmentation model was able to accurately segment the tumor region in 33 (72%) patients of the validation cohort. In the training cohort (n = 140), the radiomics-signature produced an area under the curve (AUC) of 0.87 (0.81, 0.93). Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were 0.94 (0.9, 0.98), 0.74 (0.66, 0.81), 0.72 (0.65, 0.80) and 0.97 (0.94, 1.00) respectively. In the auto-segmented validation cohort (n = 33), the radiomics model produced an AUC of 0.75 (0.61, 0.90). Sensitivity, specificity, PPV and NPV were 0.88 (0.77, 0.99), 0.62 (0.46, 0.79), 0.71 (0.56, 0.87) and 0.83 (0.71, 0.96), respectively. Conclusions: The proposed auto-segmentation model was able to automatically identify tumor regions with a high degree of accuracy. Similarly, the subsequent radiomics-signature was also able to strongly discern PNET grade. This automatic pipeline bypasses manual segmentation and could help incorporate a radiomics-signature into preoperative clinical decision-making for PNETs.

Article Details

Volume / Issue Vol. 43, Issue 4_suppl
Published February 01, 2025
Pages 655-655
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (11)

P

Pratik Chandra

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY

N

Naaz Nasar

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY

H

Hadi Ghahremannezhad

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY

K

Kevin Soares

V

Vinod P. Balachandran

J

Jeffrey A. Drebin

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY

M

Michael Ian D'Angelica

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY

T

T. Peter Kingham

W

William R. Jarnagin

J

Jayasree Chakraborty

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY

A

Alice Chia-chi Wei

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY